Paris, 18 November 2010
On 18 November 2010, Poland became the 29th member country of the OECD Nuclear Energy Agency (NEA).
"We are very pleased to welcome Poland to the OECD Nuclear Energy Agency," said NEA Director-General Luis Echávarri. "Through the NEA, Poland will draw on the world's top nuclear expertise, thus contributing to safe, environmentally friendly and economical use of nuclear energy and its applications, in line with NEA member country standards and practices. It is particularly timely as the country develops its nuclear power programme."
Minister Hanna Trojanowska, Government Commissioner for Nuclear Energy and Under-Secretary of State at the Polish Ministry of Economy, added that "NEA membership will help Poland realise the nuclear power programme which is the biggest industrial project in Poland since the Second World War." She underlined that "Poland's accession to the NEA will be beneficial to both sides because Poland will be able to provide significant input to NEA work through the engagement of Polish experts."
Poland, an OECD member country since 1996, has participated in a selection of NEA activities since 1993 and significantly increased its involvement in 2007.
In 2009, Poland's Council of Ministers adopted the "Energy Policy of Poland until 2030" which maps out a long-term plan to meet rising energy demands by diversifying power generation sources and including nuclear power in its national energy strategy. As a result, the country is currently developing a nuclear energy programme and plans to build two nuclear power reactors, the first of which is scheduled for completion in 2022.
Poland is party to the main treaties and agreements on the non-proliferation of nuclear weapons and on co-operation with regard to the peaceful uses of nuclear energy.
Poland has a significant history of scientific research and contributions in the area of nuclear energy. Poland's research reactor MARIA – named after Polish-French physicist, chemist and two-time Nobel Prize winner Marie Skłodowska-Curie – began producing medical radioisotopes this year to help address shortages in their global supply chain.